The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs

2008 Rideout, 1986, Hope, morale and adaptation in patients with chronic HF, J Adv Nurs, 11, 429, 10.1111/j.1365-2648.1986.tb01270.x Mendez, 2001, The epidemiological features of HF in developing countries: A review of the literature, Int J Cardiol, 80, 213, 10.1016/S0167-5273(01)00497-1 Yusuf, 2004, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study, Lancet, 364, 937, 10.1016/S0140-6736(04)17018-9 Krauser, 2006, Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: A ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy, J Card Fail, 12, 452, 10.1016/j.cardfail.2006.04.005 Ajayi, 1989, Enalapril in African patients with congestive cardiac failure, Br J Clin Pharmacol, 27, 400, 10.1111/j.1365-2125.1989.tb05385.x Sanderson, 1999, Beta-blockade in HF: A comparison of carvedilol with metoprolol, J Am Coll Cardiol, 34, 1522, 10.1016/S0735-1097(99)00367-8 Balarajan, 1996, Ethnicity and health: The challenges ahead, Ethn Health, 1, 3, 10.1080/13557858.1996.9961764 Wild, 1997, Cross sectional analysis of mortality by country of birth in England and Wales, 1970–92, BMJ, 314, 705, 10.1136/bmj.314.7082.705 Anand, 2000, Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: The Study of Health Assessment and Risk in Ethnic groups (SHARE), Lancet, 356, 279, 10.1016/S0140-6736(00)02502-2 Sheth, 1999, Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: An analysis of 1.2 million deaths, CMAJ, 161, 132 Kearney, 2004, Worldwide prevalence of hypertension: A systematic review, J Hypertens, 22, 11, 10.1097/00004872-200401000-00003 Ueshima, 2000, Epidemiology of hypertension in China and Japan, J Hum Hypertens, 14, 765, 10.1038/sj.jhh.1001054 Blackledge, 2003, Prognosis for South Asian and white patients newly admitted to hospital with HF in the United Kingdom: Historical cohort study, BMJ, 327, 526, 10.1136/bmj.327.7414.526 Newton, 2005, Ethnicity and variation in prognosis for patients newly hospitalised for HF: A matched historical cohort study, Heart, 91, 1545, 10.1136/hrt.2004.057935 Singh, 2005, Clinical characteristics of South Asian patients hospitalized with HF, Ethn Dis, 15, 615 Chow, 2008, Lack of awareness of heart disease and stroke among Chinese Canadians: Results of a pilot study of the Chinese Canadian Cardiovascular Health Project, Can J Cardiol, 24, 623, 10.1016/S0828-282X(08)70650-0 Mendez, 2001, The epidemiological features of HF in developing countries: A review of the literature, Int J Cardiol, 80, 213, 10.1016/S0167-5273(01)00497-1 Sanderson, 2003, HF: A global disease requiring a global response, Heart, 89, 585, 10.1136/heart.89.6.585 Sanderson, 1995, The aetiology of HF in the Chinese population of Hong Kong – a prospective study of 730 consecutive patients, Int J Cardiol, 51, 29, 10.1016/0167-5273(95)02398-G Yip, 1999, Comparison of frequencies of left ventricular systolic and diastolic HF in Chinese living in Hong Kong, Am J Cardiol, 84, 563, 10.1016/S0002-9149(99)00378-1 Tso, 2002, Cardiovascular disease in Chinese Canadians: A case-mix study from an urban tertiary care cardiology clinic, Can J Cardiol, 18, 861 Gu, 2005, Prevalence of the metabolic syndrome and overweight among adults in China, Lancet, 365, 1398, 10.1016/S0140-6736(05)66375-1 Jiang, 2009, Epidemiology and clinical management of cardiomyopathies and HF in China, Heart, 95, 1727, 10.1136/hrt.2008.150177 Yip, 2008, The Hong Kong diastolic heart failure study: A randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in HF with a normal ejection fraction, Heart, 94, 573, 10.1136/hrt.2007.117978 Chan, 1993, A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors, Eur J Clin Pharmacol, 44, 299, 10.1007/BF00271377 Woo, 1991, A high incidence of cough associated with combination therapy of hypertension with isradipine and lisinopril in Chinese subjects, Br J Clin Pract, 45, 178, 10.1111/j.1742-1241.1991.tb08850.x 2005 Ohkubo, 2004, Effects of an angiotensin-converting enzyme inhibitorbased regimen on pneumonia risk, Am J Respir Crit Care Med, 169, 1041, 10.1164/rccm.200309-1219OC Zhou, 1989, Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites, N Engl J Med, 320, 565, 10.1056/NEJM198903023200905 2007, Guidelines for the diagnosis and management of chronic HF, Zhonghua Xin Xue Guan Bing Za Zhi, 35, 1076 Miller, 1998, Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions, Arch Intern Med, 158, 2200, 10.1001/archinte.158.20.2200 Hunt, 2005, Circulation, 112, 1825, 10.1161/CIRCULATIONAHA.105.167587 Yancy, 2000, HF in African Americans: A cardiovascular engima, J Card Fail, 6, 183, 10.1054/jcaf.2000.17610 Afzal, 1999, Racial differences in patients with HF, Clin Cardiol, 22, 791, 10.1002/clc.4960221207 Bibbins-Domingo, 2009, Racial differences in incident heart failure among young adults, N Engl J Med, 360, 1179, 10.1056/NEJMoa0807265 Dries, 1999, Racial differences in the outcome of left ventricular dysfunction, N Engl J Med, 340, 609, 10.1056/NEJM199902253400804 Alexander, 1995, Hospitalization for congestive HF. Explaining racial differences, JAMA, 274, 1037, 10.1001/jama.1995.03530130043026 Ghali, 1988, Precipitating factors leading to decompensation of HF. Traits among urban Blacks, Arch Intern Med, 148, 2013, 10.1001/archinte.1988.00380090087021 Saunders, 1995, Hypertension in minorities: Blacks, Am J Hypertens, 8, 115s, 10.1016/0895-7061(95)00309-6 Exner, 2001, Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction, N Engl J Med, 344, 1351, 10.1056/NEJM200105033441802 A trial of the beta-blocker bucindolol in patients with advanced chronic HF. N Engl J Med 2001;344:1659-67. Yancy, 2001, Race and the response to adrenergic blockade with carvedilol in patients with chronic HF, N Engl J Med, 344, 1358, 10.1056/NEJM200105033441803 Goldstein, 2003, Metoprolol CR/XL in black patients with HF (from the Metoprolol CR/XL randomized intervention trial in chronic HF), Am J Cardiol, 92, 478, 10.1016/S0002-9149(03)00674-X Gottlieb, 1998, Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction, N Engl J Med, 339, 489, 10.1056/NEJM199808203390801 Carson, 1999, Racial differences in response to therapy for HF: Analysis of the vasodilator-HF trials. Vasodilator-HF Trial Study Group, J Card Fail, 5, 178, 10.1016/S1071-9164(99)90001-5 Taylor, 2004, Combination of isosorbide dinitrate and hydralazine in Blacks with HF, N Engl J Med, 351, 2049, 10.1056/NEJMoa042934 Newbold, 1998, Problems in search of solutions: Health and Canadian aboriginals, J Community Health, 23, 59, 10.1023/A:1018774921637 Anand, 2001, Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: The Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP), Lancet, 358, 1147, 10.1016/S0140-6736(01)06255-9 Shah, 2000, Increasing rates of ischemic heart disease in the native population of Ontario, Canada, Arch Intern Med, 160, 1862, 10.1001/archinte.160.12.1862 Burrows, 2000, Prevalence of diabetes among Native Americans and Alaska Natives, 1990-1997: An increasing burden, Diabetes Care, 23, 1786, 10.2337/diacare.23.12.1786 Fagot-Campagna, 2000, Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective, J Pediatr, 136, 664, 10.1067/mpd.2000.105141 Tonelli, 2004, Death and renal transplantation among Aboriginal people undergoing dialysis, CMAJ, 171, 577, 10.1503/cmaj.1031859 Australian Institute of Health and Welfare. Cardiovascular disease and its associated risk factors in Aboriginal and Torres Strait Islander peoples 2004-2005. Cardiovascular Disease Series Number 29. <www.aihw.gov.au/publications/index.cfm/title/10549>.(Accessed on June 18, 2009). Macaulay, 2009, Improving aboriginal health: How can health care professionals contribute?, Can Fam Physician, 55, 334 Hoy, 2005, A chronic disease outreach program for Aboriginal communities, Kidney Int Suppl, S76, 10.1111/j.1523-1755.2005.09814.x Hunter, 1992, Adaptation of the maternal heart in pregnancy, Br Heart J, 68, 540, 10.1136/hrt.68.12.540 Crapo, 1996, Normal cardiopulmonary physiology during pregnancy, Clin Obstet Gynecol, 39, 3, 10.1097/00003081-199603000-00004 Clark, 1989, Central hemodynamic assessment of normal term pregnancy, Am J Obstet Gynecol, 161, 1439, 10.1016/0002-9378(89)90900-9 Capeless, 1989, Cardiovascular changes in early phase of pregnancy, Am J Obstet Gynecol, 161, 1449, 10.1016/0002-9378(89)90902-2 Lee, 1991, Cardiorespiratory alterations during normal pregnancy, Crit Care Clin, 7, 763, 10.1016/S0749-0704(18)30279-3 Duvekot, 1993, Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone, Am J Obstet Gynecol, 169, 1382, 10.1016/0002-9378(93)90405-8 Gant, 1980, Control of vascular responsiveness during human pregnancy, Kidney Int, 18, 253, 10.1038/ki.1980.133 Kametas, 2003, Maternal cardiac function in twin pregnancy, Obstet Gynecol, 102, 806 Robson, 1989, Serial study of factors influencing changes in cardiac output during human pregnancy, Am J Physiol, 256, H1060 Van Oppen, 1996, Cardiac output in normal pregnancy: A critical review, Obstet Gynecol, 87, 310, 10.1016/0029-7844(95)00348-7 Desai, 2004, Echocardiographic assessment of cardiovascular hemodynamics in normal pregnancy, Obstet Gynecol, 104, 20, 10.1097/01.AOG.0000128170.15161.1d Mabie, 1994, A longitudinal study of cardiac output in normal human pregnancy, Am J Obstet Gynecol, 170, 849, 10.1016/S0002-9378(94)70297-7 Kinsella, 1994, Supine hypotensive syndrome, Obstet Gynecol, 83, 774 Avila, 2003, Pregnancy in patients with heart disease: Experience with 1000 cases, Clin Cardiol, 26, 135, 10.1002/clc.4960260308 Bernstein, 2001, Cardiomyopathy in pregnancy: A retrospective study, Am J Perinatol, 18, 163, 10.1055/s-2001-14525 Cutforth, 1966, Heart sounds and murmurs in pregnancy, Am Heart J, 71, 741, 10.1016/0002-8703(66)90594-1 Northcote, 1985, Systolic murmurs in pregnancy: Value of echocardiographic assessment, Clin Cardiol, 8, 327, 10.1002/clc.4960080604 Oram, 1961, Innocent depression of the S-T segment and flattening of the T-wave during pregnancy, J Obstet Gynaecol Br Emp, 68, 765, 10.1111/j.1471-0528.1961.tb02807.x Campos, 1993, Physiologic multivalvular regurgitation during pregnancy: A longitudinal Doppler echocardiographic study, Int J Cardiol, 40, 265, 10.1016/0167-5273(93)90010-E Desai, 2004, Echocardiographic assessment of cardiovascular hemodynamics in normal pregnancy, Obstet Gynecol, 104, 20, 10.1097/01.AOG.0000128170.15161.1d Arnold, 2007, Canadian Cardiovascular Society Consensus Conference recommendation on HF update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers, Can J Cardiol, 23, 21, 10.1016/S0828-282X(07)70211-8 Resnik, 2005, Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women, Am J Obstet Gynecol, 193, 450, 10.1016/j.ajog.2004.12.006 Folk, 2005, Evaluating ventricular function with B-type natriuretic peptide in obstetric patients, J Reprod Med, 50, 147 McFaul, 1988, Pregnancy complicated by maternal heart disease: A review of 519 women, Br J Obstet Gynecol, 95, 861, 10.1111/j.1471-0528.1988.tb06570.x Siu, 2001, Prospective multicentre study of pregnancy outcome in women with heart disease, Circulation, 104, 515, 10.1161/hc3001.093437 Sermer, 2003, Pregnancy complicated by heart disease: A review of Canadian Experience, J Obstet Gynecol, 23, 540, 10.1080/0144361031000153492 Kovacs, 2008, Pregnancy and contraception in congenital heart disease: What women are not told, J Am Coll Cardiol, 52, 577, 10.1016/j.jacc.2008.05.013 American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(6 Suppl):844S-886S. Heider, 1999, Peripartum cardiomyopathy: A review of the literature, Obstet Gynecol Surv, 45, 526, 10.1097/00006254-199908000-00023 Sharrock, 1994, Deliberate hypotensive epidural anaesthesia for patients with normal and low cardiac output, Anesth Analg, 79, 899, 10.1213/00000539-199411000-00014 George, 1997, Peripartum cardiomyopathy: Four case histories and a commentary on anaesthetic management, Anaesth Intensive Care, 25, 292, 10.1177/0310057X9702500317 Pirlet, 2000, Low dose combined spinal-epidural anaesthesia for caesarean section in a patient with peripartum cardiomyopathy, Int J Obstet Anesth, 9, 189, 10.1054/ijoa.1999.0374 Shnaider, 2001, Combined spinal – epidural anaesthesia for cesarean section in a patient with peripartum dilated cardiomyopathy, Can J Anaesth, 48, 681, 10.1007/BF03016203 Kotekar, 2007, Chandrashekar. A rare case of peripartum cardiomyopathy posted for caesarian section, Indian J Anaesth, 51, 60 Pryn, 2007, Cardiomyopathy in pregnancy and casesarean section: Four case reports, Int J Obstet Anesth, 16, 68, 10.1016/j.ijoa.2006.07.006 Dob, 2006, Practical management of the parturient with congenital heart disease, Int J Obstet Anesth, 15, 137, 10.1016/j.ijoa.2005.07.005 Demakis, 1971, Natural course of peripartum cardiomyopathy, Circulation, 44, 1053, 10.1161/01.CIR.44.6.1053 Elliott, 2008, Classification of the cardiomyopathies: A position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 29, 270, 10.1093/eurheartj/ehm342 Elkayam, 2005, Pregnancy-associated cardiomyopathy: Clinical characteristics and a comparison between early and late presentation, Circulation, 111, 2050, 10.1161/01.CIR.0000162478.36652.7E Mielniczuk, 2006, Frequency of peripartum cardiomyopathy, Am J Cardiol, 97, 1765, 10.1016/j.amjcard.2006.01.039 Pearson, 2000, Peripartum cardidomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National INstitues of Health) workshop recommendations and review, JAMA, 283, 1183, 10.1001/jama.283.9.1183 Bultmann, 2005, High prevalence of viral genomes and inflammation in peripartum cardiomyopathy, Am J Obstet Gyn, 193, 363, 10.1016/j.ajog.2005.01.022 Kuhl, 2005, Viral persistence in the myocardium is associated with progressive cardiac dysfunction, Circulation, 112, 1965, 10.1161/CIRCULATIONAHA.105.548156 Ansari, 2002, Autoimmune mechanisms as the basis for human peripartum cardiomyopathy, Clin Rev Allergy Immunol, 23, 289, 10.1385/CRIAI:23:3:301 Melvin, 1982, Peripartum cardiomyopathy due to myocarditis, N Engl J Med, 307, 731, 10.1056/NEJM198209163071207 Sanderson, 1986, Peripartum heart disease: An endomyocardial biopsy study, Br Heart J, 56, 285, 10.1136/hrt.56.3.285 Midei, 1990, Peripartum myocarditis and cardiomyopathy, Circulation, 81, 922, 10.1161/01.CIR.81.3.922 Rizeq, 1994, Incidence of myocarditis in peripartum cardiomyopathy, Am J Cardiol, 74, 474, 10.1016/0002-9149(94)90906-7 Narula, 1996, Apoptosis in myocytes in end-stage HF, N Eng J Med, 335, 1182, 10.1056/NEJM199610173351603 Hayakawa, 2003, Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice, Circulation, 108, 3036, 10.1161/01.CIR.0000101920.72665.58 Artlett, 1998, Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis, N Eng J Med, 338, 1186, 10.1056/NEJM199804233381704 Nelson, 2001, Microchimerism: Expanding new horizon in human health or incidental remnant of pregnancy?, Lancet, 358, 2011, 10.1016/S0140-6736(01)07134-3 Hilfiker-Kleiner, 2007, A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy, Cell, 128, 437, 10.1016/j.cell.2006.12.036 Hilfiker-Kleiner, 2007, Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine, J Am Coll Cardiol, 50, 2354, 10.1016/j.jacc.2007.10.006 Aziz, 1999, Heart transplantation for peripartum cardiomyopathy: A report of three cases and a literature review, Cardiovasc Surg, 7, 565, 10.1016/S0967-2109(99)00014-9 Amos, 2006, Improved outcomes in peripartum cardiomyopathy with contemporary, Am Heart J, 152, 509, 10.1016/j.ahj.2006.02.008 Pulerwitz, 2004, Mortality in primary and secondary myocarditis, Am Heart J, 147, 746, 10.1016/j.ahj.2003.10.029 Sliwa, 2006, Peripartum cardiomyopathy, Lancet, 368, 687, 10.1016/S0140-6736(06)69253-2 Fett, 2005, Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution, Mayo Clinic Proc, 80, 1602, 10.4065/80.12.1602 Lampert, 1997, Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function, Am J Obstet Gynecol, 176, 189, 10.1016/S0002-9378(97)80034-8 Sliwa, 2000, Peripartum cardiomyopathy: Analysis of clinical outcome, left ventricular function, plasma levels of cytokines, and Fas/Apo-1, J Am Coll Cardiol, 35, 701, 10.1016/S0735-1097(99)00624-5 Elkayam, 2001, Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy, N Engl J Med, 344, 1567, 10.1056/NEJM200105243442101 Habli, 2008, Peripartum cardiomyopathy: Prognostic factors for long-term maternal outcome, Am J Obstet Gynecol, 199, 10.1016/j.ajog.2008.06.087 Faxon, 2004, American Heart Association's Expert Panel on Disease Management, Circulation, 109, 2651, 10.1161/01.CIR.0000128373.90851.7B Hauptman, 2008, The HF clinic: A consensus statement of the HF Society of America, J Cardiac Fail, 14, 801, 10.1016/j.cardfail.2008.10.005 Yu, 2006, Disease management programmes for older people with HF: Crucial characteristics which improve post-discharge outcomes, Eur Heart J, 27, 596, 10.1093/eurheartj/ehi656 Roccaforte, 2005, Effectiveness of comprehensive disease management programmes in improving clinical outcomes in HF patients. A meta-analysis, Eur J Heart Fail, 7, 1133, 10.1016/j.ejheart.2005.08.005 Phillips, 2005, Complexity of program and clinical outcomes of HF disease management incorporating specialist nurse-led HF clinics. A meta-regression analysis, Eur J Heart Fail, 7, 333, 10.1016/j.ejheart.2005.01.011 Gonseth, 2004, The effectiveness of disease management programmes in reducing hospital re-admission in older patients with HF: A systematic review and meta-analysis of published reports, Eur Heart J, 25, 1570, 10.1016/j.ehj.2004.04.022 Whellan, 2005, Metaanalysis and review of HF disease management randomized controlled clinical trials, Am Heart J, 149, 722, 10.1016/j.ahj.2004.09.023 McAlister, 2004, Multidisciplinary strategies for the management of HF patients at high risk for admission, J Am Coll Cardiol, 44, 810 Ducharme, 2005, Impact of care at a multidisciplinary congestive HF clinic: A randomized trial, CMAJ, 173, 40, 10.1503/cmaj.1041137 Dunagan, 2005, Randomized trial of a nurse-administered, telephone-based disease management program for patients with HF, J Cardiac Fail, 11, 358, 10.1016/j.cardfail.2004.12.004 Bruggink-André de la Porte, 2007, Added value of a physician-and-nurse-directed HF clinic: Results from the Deventer-Alkmaar HF study, Heart, 93, 819, 10.1136/hrt.2006.095810 Del Sindaco, 2007, Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with HF, J Cardiovascular Med, 8, 324, 10.2459/JCM.0b013e32801164cb Cleland, 2005, Noninvasive home telemonitoring for patients with HF at high risk of recurrent admission and death. The Trans-European Network-Home-Care Management System (TEN-HMS) Study, J Am Coll Cardiol, 45, 1654, 10.1016/j.jacc.2005.01.050 Galbreath, 2004, Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with HF, Circulation, 110, 3518, 10.1161/01.CIR.0000148957.62328.89 2005, Randomized trial of telephone intervention in chronic HF: DIAL trial, BMJ, 331, 425, 10.1136/bmj.38516.398067.E0 Jaarsma, 2008, Effect of moderate or intensive disease management program on outcome in patients with HF, Arch Intern Med, 168, 316, 10.1001/archinternmed.2007.83 Nguyen, 2007, Lack of long-term benefits of a 6-month HF disease management program, J Cardiac Fail, 13, 287, 10.1016/j.cardfail.2007.01.002 Houde S, Feldman DE, Pilote L, et al. Are there sex-related differences in specialized, multidisciplinary congestive HF clinics? Can J Cardiol 23:451–5. Koshman, 2008, Pharmacist care of patients with heart failure: A systematic review of randomized trials, Arch Intern Med, 168, 687, 10.1001/archinte.168.7.687 Phillips, 2004, Comprehensive discharge planning with postdischarge support for older patients with congestive HF: A meta-analysis, JAMA, 291, 1358, 10.1001/jama.291.11.1358 Gregory, 2006, Hospital cost effect of a HF disease management program: The specialized primary and networked care in HF (SPAN-CHF) trial, Am Heart J, 151, 1013, 10.1016/j.ahj.2005.06.039 Hebert, 2008, Cost-effectiveness of nurse-led disease management for HF in an ethnically diverse urban community, Ann Intern Med, 149, 540, 10.7326/0003-4819-149-8-200810210-00006 Turner, 2008, Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and HF in primary care, Heart, 94, 1601, 10.1136/hrt.2007.125708 Whellan, 2007, Financial implications of a model HF disease management program for providers, hospital, healthcare systems, and payer perspectives, Am J Cardiol, 99, 256, 10.1016/j.amjcard.2006.08.019 2001 Fishman, 2004, Opportunities and challenges for measuring cost, quality, and clinical effectiveness in health care, Med Care Res Rev, 61, 124S, 10.1177/1077558704267512 Rubin, 2001, The advantages and disadvantages of process-based measures of health care quality, Int J Qual Health Care, 13, 469, 10.1093/intqhc/13.6.469 Mant, 2001, Process versus outcome indicators in the assessment of quality of health care, Int J Qual Health Care, 13, 475, 10.1093/intqhc/13.6.475 Campbell, 2003, Research methods used in developing and applying quality indicators in primary care, BMJ, 326, 816, 10.1136/bmj.326.7393.816 Donabedian, 1988, Quality assessment and assurance: Unity of purpose, diversity of means, Inquiry, 25, 173 Tu, 2009, National trends in rates of death and hospital admissions related to acute myocardial infarction, HF and stroke, 1994-2004, CMAJ, 180, 1304, 10.1503/cmaj.081197 Litaker, 2003, Patterns of pharmacologic treatment of congestive HF in elderly nursing home residents and related issues: A review of the literature, Clin Ther, 25, 1918, 10.1016/S0149-2918(03)80196-0 Rangaswamy, 2005, Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with HF and left ventricular systolic dysfunction, Cardiology, 103, 17, 10.1159/000081847 Shibata, 2005, Utilization of evidence-based therapies for HF in the institutionalized elderly, Eur J Heart Fail, 7, 1122, 10.1016/j.ejheart.2005.03.005 De Groote, 2007, Is the gap between guidelines and clinical practice in HF treatment being filled? Insights from the IMPACT RECO study, Eur J Heart Fail, 9, 1205, 10.1016/j.ejheart.2007.09.008 Cleland, 2002, Management of HF in primary care (the IMPROVEMENT of HF Programme): An international survey, Lancet, 360, 1631, 10.1016/S0140-6736(02)11601-1 Goodlin, 2009, Palliative care in congestive HF, J Am Coll Cardiol, 54, 386, 10.1016/j.jacc.2009.02.078 Lee, 2003, Canadian Cardiovascular Outcomes Research Team/Canadian Cardiovascular Society HF Quality Indicator Panel. CCORT/CCS quality indicators for congestive HF care, Can J Cardiol, 19, 357 Bonow, 2008, J Am Coll Cardiol, 52, 2113, 10.1016/j.jacc.2008.10.014 Joint Commission on Accreditation of Healthcare Organizations. Specifications Manual for National Hospital Quality Measures. 2006. Heidenreich, 2007, Quality indicators for the care of HF in vulnerable elders, J Am Geriatr Soc, 55, S340, 10.1111/j.1532-5415.2007.01341.x Heidenreich, 2008, Improving HF care with a reminder attached to the echocardiography, Am J Med, 121, 853, 10.1016/j.amjmed.2008.06.021 Ansari, 2003, Improving guideline adherence: A randomized trial evaluating strategies to increase beta-blocker use in HF, Circulation, 107, 2799, 10.1161/01.CIR.0000070952.08969.5B Frijling, 2003, Intensive support to improve clinical decision making in cardiovascular care: A randomised controlled trial in general practice, Qual Saf Health Care, 12, 181, 10.1136/qhc.12.3.181 Thilly, 2003, Improving ACE inhibitor use in patients hospitalized with systolic HF: A cluster randomized controlled trial of clinical practice guideline development and use, J Eval Clin Pract, 9, 373, 10.1046/j.1365-2753.2003.00441.x Tierney, 2003, Effects of computerized guidelines for managing heart disease in primary care, J Gen Intern Med, 18, 967, 10.1111/j.1525-1497.2003.30635.x Feldman, 2004, A randomized intervention to improve HF outcomes in community-based home health care, Home Health Care Serv Q, 23, 1, 10.1300/J027v23n01_01 Guadagnoli, 2004, Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or HF, Am J Med, 117, 371, 10.1016/j.amjmed.2004.04.013 LaPointe, 2006, Multifaceted intervention to promote beta-blocker use in HF, Am Heart J, 151, 992, 10.1016/j.ahj.2005.06.038 Majumdar, 2007, Impact of opinion leaderendorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: A randomized controlled trial, Am Heart J, 153, 10.1016/j.ahj.2006.07.030 Gardetto, 2008, Critical pathway for the management of acute HF at the Veterans Affairs San Diego Healthcare System: Transforming performance measures into cardiac care, Crit Pathw Cardiol, 7, 153, 10.1097/HPC.0b013e31818207e4 Peters-Klimm, 2008, Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice – results from a cluster-randomized controlled trial of implementation of a clinical practice guideline, J Eval Clin Pract, 14, 823, 10.1111/j.1365-2753.2008.01060.x Greenhalgh, 2004, Diffusion of innovations in service organizations: Systematic review and recommendations, Milbank Q, 82, 581, 10.1111/j.0887-378X.2004.00325.x Mollon, 2009, Features predicting the success of computerized decision support for prescribing: A systematic review of randomized controlled trials, BMC Med Inform Decis Mak, 9, 11, 10.1186/1472-6947-9-11 Jamtvedt, 2006, Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback, Qual Saf Health Care, 15, 433, 10.1136/qshc.2006.018549 Werner, 2006, Relationship between Medicare's hospital compare performance measures and mortality rates, JAMA, 296, 2694, 10.1001/jama.296.22.2694 Albert, 2007, Predictors of delivery of hospital-based heart failure patient education: A report from OPTIMIZE-HF, J Card Fail, 13, 189, 10.1016/j.cardfail.2006.11.008 Fonarow, 2007, Influence of a performanceimprovement initiative on quality of care for patients hospitalized with HF: Results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF), Arch Intern Med, 167, 1493, 10.1001/archinte.167.14.1493 Fonarow, 2007, Association between performance measures and clinical outcomes for patients hospitalized with HF, JAMA, 297, 61, 10.1001/jama.297.1.61 Fonarow, 2007, Improving the use of evidence-based heart failure therapies in the outpatient setting: The IMPROVE HF performance improvement registry, Am Heart J, 154, 12, 10.1016/j.ahj.2007.03.030 Yancy, 2009, Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF, Am Heart J, 157, 754, 10.1016/j.ahj.2008.12.016 Fonarow, 2004, Overview of acutely decompensated congestive HF (ADHF): A report from the ADHERE registry, Heart Fail Rev, 9, 179, 10.1007/s10741-005-6127-6 Yancy, 2004, Quality of care and outcomes in acute decompensated HF: The ADHERE Registry, Curr Heart Fail Rep, 1, 121, 10.1007/s11897-004-0021-8 Fonarow, 2005, Adherence to HF quality-of-care indicators in US hospitals: Analysis of the ADHERE Registry, Arch Intern Med, 165, 1469, 10.1001/archinte.165.13.1469 Fonarow, 2007, Temporal trends in clinical characteristics, treatments, and outcomes for HF hospitalizations, 2002 to 2004: Findings from Acute Decompensated HF National Registry (ADHERE), Am Heart J, 153, 1021, 10.1016/j.ahj.2007.03.012 Filardo, 2009, A hospital-randomized controlled trial of a formal quality improvement educational program in rural and small community Texas hospitals: One year results, Int J Qual Health Care, 21, 225, 10.1093/intqhc/mzp019 Tu, 2009, Effectiveness of public report cards for improving the quality of cardiac care: The EFFECT study: A randomized trial, JAMA, 302, 2330, 10.1001/jama.2009.1731 Fonarow, 2009, HF. performance measures and outcomes: Real or illusory gains, JAMA, 302, 792, 10.1001/jama.2009.1180 Arnold, 2006, Canadian Cardiovascular Society consensus conference recommendations on HF 2006: Diagnosis and management, Can J Cardiol, 22, 23, 10.1016/S0828-282X(06)70237-9 Arnold, 2007, Canadian Cardiovascular Society Consensus Conference recommendations on HF update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers, Can J Cardiol, 23, 21, 10.1016/S0828-282X(07)70211-8 Arnold, 2008, Canadian Cardiovascular Society Consensus Conference guidelines on HF – 2008 update: Best practices for the transition of care of HF patients, and the recognition, investigation and treatment of cardiomyopathies, Can J Cardiol, 24, 21, 10.1016/S0828-282X(08)70545-2 Perrin, 1998, Effective use and misuse of performance measurement, Am J Eval, 19, 367, 10.1177/109821409801900308 McDonald KM, Sundaram V, Bravata DM, et al. Care coordination. In: Shojania KG, McDonald KM, Wachter RM, Owens DK, eds. Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies. Technical Review 9 (Prepared by the Stanford University-UCSF Evidence-based Practice Center under contract 290-02-0017). AHRQ Publication No 04(07)-0051-7. Rockville: Agency for Healthcare Research and Quality, 2007. Peikes, 2009, Effects of care coordination on hospitalization, quality of care, and health care expenditures among Medicare beneficiaries, JAMA, 301, 603, 10.1001/jama.2009.126 Niessen, 2000, The evidence-based approach to health policy and heath care delivery, Soc Sci Med, 51, 859, 10.1016/S0277-9536(00)00066-6 Klazinga, 2000, Re-engineering trust: The adoption and adaption of four models for external quality assurance of health care services in western European health care systems, Int J Qual Health Care, 12, 183, 10.1093/intqhc/12.3.183 Burge, 2007, Quality indicators for cardiovascular primary care, Can J Cardiol, 23, 383, 10.1016/S0828-282X(07)70772-9